Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

Rationale and timing of perioperative chemotherapy for upper-tract urothelial carcinoma.

Lin YK, Kaag M, Raman JD.

Expert Rev Anticancer Ther. 2014 May;14(5):543-51. doi: 10.1586/14737140.2014.882774. Epub 2014 Mar 26.

PMID:
24666189
2.

Urothelial carcinoma of the bladder and the upper tract: disparate twins.

Green DA, Rink M, Xylinas E, Matin SF, Stenzl A, Roupret M, Karakiewicz PI, Scherr DS, Shariat SF.

J Urol. 2013 Apr;189(4):1214-21. doi: 10.1016/j.juro.2012.05.079. Epub 2012 Sep 27. Review.

PMID:
23023150
3.

USANZ: Time-trends in use and impact on outcomes of perioperative chemotherapy in patients treated with radical cystectomy for urothelial bladder cancer.

Liew MS, Azad A, Tafreshi A, Eapen R, Bolton D, Davis ID, Sengupta S.

BJU Int. 2013 Nov;112 Suppl 2:74-82. doi: 10.1111/bju.12384.

4.

Long-term endoscopic management of upper tract urothelial carcinoma: 20-year single-centre experience.

Cutress ML, Stewart GD, Wells-Cole S, Phipps S, Thomas BG, Tolley DA.

BJU Int. 2012 Dec;110(11):1608-17. doi: 10.1111/j.1464-410X.2012.11169.x. Epub 2012 May 7.

5.

Role of systemic chemotherapy in urothelial urinary bladder cancer.

Gupta S, Mahipal A.

Cancer Control. 2013 Jul;20(3):200-10. Review.

6.

Adjuvant and neoadjuvant chemotherapy for urothelial carcinoma.

McCaffrey JA, Herr HW.

Surg Oncol Clin N Am. 1997 Oct;6(4):667-81. Review.

PMID:
9309087
7.

Chemotherapy for bladder cancer: treatment guidelines for neoadjuvant chemotherapy, bladder preservation, adjuvant chemotherapy, and metastatic cancer.

Sternberg CN, Donat SM, Bellmunt J, Millikan RE, Stadler W, De Mulder P, Sherif A, von der Maase H, Tsukamoto T, Soloway MS.

Urology. 2007 Jan;69(1 Suppl):62-79. Review.

PMID:
17280909
8.

Prognostic significance of non-muscle-invasive bladder tumor history in patients with upper urinary tract urothelial carcinoma.

Milojevic B, Djokic M, Sipetic-Grujicic S, Grozdic Milojevic I, Vuksanovic A, Nikic P, Vukovic I, Djordjevic D, Bumbasirevic U, Tulic C.

Urol Oncol. 2013 Nov;31(8):1615-20. doi: 10.1016/j.urolonc.2012.03.004. Epub 2012 Apr 21.

PMID:
22521771
9.

Neoadjuvant chemotherapy for bladder cancer.

Sonpavde G, Lerner SP.

Oncology (Williston Park). 2007 Dec;21(14):1673-81; discussion 1686-8, 1691, 1694. Review.

10.

Ureteroscopic and extirpative treatment of upper urinary tract urothelial carcinoma: a 15-year comprehensive review of 160 consecutive patients.

Grasso M, Fishman AI, Cohen J, Alexander B.

BJU Int. 2012 Dec;110(11):1618-26. doi: 10.1111/j.1464-410X.2012.11066.x. Epub 2012 Mar 28.

11.

Lymphadenectomy at the time of nephroureterectomy for upper tract urothelial cancer.

Roscigno M, Brausi M, Heidenreich A, Lotan Y, Margulis V, Shariat SF, Van Poppel H, Zigeuner R.

Eur Urol. 2011 Oct;60(4):776-83. doi: 10.1016/j.eururo.2011.07.009. Epub 2011 Jul 14. Review.

PMID:
21798659
12.

A systematic overview of chemotherapy effects in urothelial bladder cancer.

Nilsson S, Ragnhammar P, Glimelius B, Nygren P; SBU-group. Swedish Council of Technology Assessment in Health Care.

Acta Oncol. 2001;40(2-3):371-90. Review.

PMID:
11441942
13.

Bacillus Calmette-Guérin failure in patients with non-muscle-invasive urothelial carcinoma of the bladder may be due to the urologist's failure to detect urothelial carcinoma of the upper urinary tract and urethra.

Giannarini G, Birkhäuser FD, Recker F, Thalmann GN, Studer UE.

Eur Urol. 2014 Apr;65(4):825-31. doi: 10.1016/j.eururo.2013.09.049. Epub 2013 Oct 9.

PMID:
24144432
14.

The role of systemic chemotherapy in management of upper tract urothelial cancer.

Gayed BA, Thoreson GR, Margulis V.

Curr Urol Rep. 2013 Apr;14(2):94-101. doi: 10.1007/s11934-013-0307-z. Review.

PMID:
23344684
15.

Adjuvant chemotherapy for invasive urothelial cancer: experience with a methotrexate, vincristine, cisplatin, cyclophosphamide, adriamycin and bleomycin (MVP-CAB) regimen: a preliminary report.

Gohji K, Higuchi A, Maruyama S, Minayoshi K, Fujii A, Itoh N, Hasunuma Y, Tanaka H, Izumi T.

Jpn J Clin Oncol. 1993 Oct;23(5):291-8.

PMID:
7693990
16.

Oncologic outcomes obtained after neoadjuvant and adjuvant chemotherapy for the treatment of urothelial carcinomas of the upper urinary tract: a review.

Cordier J, Sonpavde G, Stief CG, Tilki D.

World J Urol. 2013 Feb;31(1):77-82. doi: 10.1007/s00345-012-0960-8. Epub 2012 Sep 29. Review.

PMID:
23053212
17.

Adjuvant and neoadjuvant chemotherapy for bladder cancer: management and controversies.

Garcia JA, Dreicer R.

Nat Clin Pract Urol. 2005 Jan;2(1):32-7. Review.

PMID:
16474574
18.

The role of chemotherapy in the treatment of urothelial cell carcinoma of the upper urinary tract (UUT-UCC).

Audenet F, Yates DR, Cussenot O, Rouprêt M.

Urol Oncol. 2013 May;31(4):407-13. doi: 10.1016/j.urolonc.2010.07.016. Epub 2010 Sep 29. Review.

PMID:
20884249
19.

Neoadjuvant and adjuvant chemotherapy in muscle-invasive bladder cancer.

Calabrò F, Sternberg CN.

Eur Urol. 2009 Feb;55(2):348-58. doi: 10.1016/j.eururo.2008.10.016. Epub 2008 Oct 16. Review.

PMID:
18977070
20.

Ureteroscopic and percutaneous management of upper tract urothelial carcinoma (UTUC): systematic review.

Cutress ML, Stewart GD, Zakikhani P, Phipps S, Thomas BG, Tolley DA.

BJU Int. 2012 Sep;110(5):614-28. doi: 10.1111/j.1464-410X.2012.11068.x. Epub 2012 Apr 3. Review.

Supplemental Content

Support Center